They 3D Printed a Kidney in Space? | Jana Stoudemire, Innovian Space | The Biotech Voyager

This week, Innovian Space printed the first kidney and liver constructs in human history on the International Space Station. Jana Studemeier, CCO at Innovian Space, joins The Biotech Voyager to explain why gravity is the single biggest obstacle to printing functional organs, why microgravity solves it, and how the cost of a space experiment is nothing compared to the cost of a failed clinical trial. From Keytruda being reformulated using protein crystallization in space, to tumor organoids that behave more like real tumors in microgravity, to the coming explosion in regenerative medicine — this is the most unexpected biotech conversation we've had. Jana Studemeier is CCO at Innovian Space, a company helping organizations develop profitable and sustainable uses of space for biotech, pharma, and beyond. Chapters 00:00:00 Welcome: Jana Studemeier, Innovian Space 00:01:33 Printing Kidneys on the ISS This Week 00:03:10 Why Microgravity Changes Everything 00:06:26 Why 3D Printing Fails on Earth 00:10:23 Drug Testing With Tumor Organoids in Space 00:12:25 The Cost of Space vs Failing in Trials 00:19:18 Keytruda Was Reformulated Using Space 00:28:44 Space Will Cause a Regenerative Medicine Explosion New episodes every Tuesday and Thursday at 11:00 AM 🚀